Skip to main content
. 2023 Mar 23;28(7):2890. doi: 10.3390/molecules28072890

Figure 6.

Figure 6

Structure of phenylglycine-based inhibitors and radiolabeled analogs. (A) Structure of preclinical and clinical mIDH1-selective inhibitors with an N-acetyl phenylglycine amide backbone (highlighted in blue) [65,70,71,73]. (B) Overview of radiolabeled phenylglycine-based inhibitors of mIDH1 (radiolabels highlighted in red) [62,74].